The development of methods for the evaluation of DBS leads and other DB therapies in preclinical animal models

Medtronic continues to develop products for deep brain stimulation (DBS) for the treatment of movement disorders including Parkinson ’s disease (PD), essential tremor (ET), dystonia, and other neurological disorders such as epilepsy and obsessive-compulsive disorder (OCD). As part of the development process, the effectiveness and safety of new products must be evaluated before initiation of clinical trials. While some evaluatio ns can be performed with bench testing and simulation, regulatory agencies often require in vivo testing in preclinical animal models.
Source: BRAIN STIMULATION: Basic, Translational, and Clinical Research in Neuromodulation - Category: Neurology Authors: Source Type: research